Singapore Paincare Holdings (SGX:FRQ) Other Stockholders Equity: S$-5.38 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Singapore Paincare Holdings Other Stockholders Equity?

Singapore Paincare Holdings SGX:FRQ Other Stockholders Equity is S$-5.38 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Singapore Paincare Holdings's Other Stockholders Equity for the quarter that ended in Dec. 2025 was S$-5.38 Mil.

Singapore Paincare Holdings's quarterly Other Stockholders Equity declined from Dec. 2024 (S$-5.38 Mil) to Jun. 2025 (S$-5.38 Mil) but then stayed the same from Jun. 2025 (S$-5.38 Mil) to Dec. 2025 (S$-5.38 Mil).

Singapore Paincare Holdings's annual Other Stockholders Equity stayed the same from Jun. 2023 (S$-5.38 Mil) to Jun. 2024 (S$-5.38 Mil) and stayed the same from Jun. 2024 (S$-5.38 Mil) to Jun. 2025 (S$-5.38 Mil).

Singapore Paincare Holdings Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Singapore Paincare Holdings's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singapore Paincare Holdings Other Stockholders Equity Chart

Singapore Paincare Holdings Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only -5.38 -5.38 -5.38 -5.38 -5.38

Singapore Paincare Holdings Semi-Annual Data
Jun17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.46 -5.38 -5.38 -5.38 -5.38

Singapore Paincare Holdings Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of S$-5.38 Mil mean?
Singapore Paincare Holdings (SGX:FRQ) has a Other Stockholders Equity of S$-5.38 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Singapore Paincare Holdings and its competitors.
Is Singapore Paincare Holdings' Other Stockholders Equity too high?
Singapore Paincare Holdings' current Other Stockholders Equity is S$-5.38 Mil.
How does Singapore Paincare Holdings' Other Stockholders Equity compare to HCA and THC?
Singapore Paincare Holdings' Other Stockholders Equity of S$-5.38 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Singapore Paincare Holdings and its competitors. Singapore Paincare Holdings's current Other Stockholders Equity is S$-5.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Paincare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Singapore Paincare Holdings (SGX:FRQ) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.17, compared to a current price of S$0.06 — trading 64.7% below its estimated fair value. The current Other Stockholders Equity is S$-5.38 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Singapore Paincare Holdings (SGX:FRQ), the current Other Stockholders Equity is S$-5.38 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Singapore Paincare Holdings Business Description

Address 601 Macpherson Road, No. 06-20/21 Grantral Mall, Singapore, SGP, 368242
Singapore Paincare Holdings Ltd is a medical services group engaged in pain care services, primary care, and other services. It offers Pain care services focused on the treatment of patients suffering from chronic pain. Its pain care services include, among others, minimally invasive procedures, cancer pain treatment, specialised injections, pharmacotherapy, and cognitive behavioural therapy. Its Primary care and other services provide general medical consultations, management of chronic and acute conditions, and dermatology services. Through its associated company, it also provides health screening services. The company operates mainly in Singapore.